Establishes provisions governing the prescribing, dispensing and administering of medication designed to end the life of a patient. (BDR 40-600)

(Reprinted with amendments adopted on April 15, 2025)
FIRST REPRINT A.B. 346

- *AB346_R1*

ASSEMBLY BILL NO. 346–ASSEMBLYMEMBERS
DALIA AND GALLANT

MARCH 3, 2025
____________

JOINT SPONSOR: SENATOR FLORES
____________

Referred to Select Committee on End-of-Life Care

SUMMARY—Establishes provisions governing the prescribing,
dispensing and administering of medication designed
to end the life of a patient. (BDR 40-600)

FISCAL NOTE: Effect on Local Government: No.
Effect on the State: Yes.

~

EXPLANATION – Matter in bolded italics is new; matter between brackets [omitted material] is material to be omitted.

AN ACT relating to health care; revising provisions concerning
medical certificates of death of persons who self -administer
a medication that is designed to end the life of the person;
authorizing a physician or advanced practice registered nurse
to prescribe a medication that is designed to end the life of a
patient under certain circumstances; prohibiting persons
other than a patient from administering a medicat ion that is
designed to end the life of the patient; imposing
requirements relating to the medical records of a patient who
requests a medication that is designed to end the life of the
patient; providing immunity to certain providers of health
care and he alth care facilities for certain actions relating to
prescribing or dispensing a medication that is designed to
end the life of a patient; authorizing the owner or operator of
a health care facility to prohibit the provision of certain
services relating to a medication that is designed to end the
life of a patient; prohibiting a person from including certain
provisions in a will, contract, agreement or policy of life
insurance; prohibiting certain actions on a policy of life
insurance because the insured requested or revoked a request
for a medication that is designed to end the life of the
insured; and providing other matters properly relating
thereto.

– 2 –

- *AB346_R1*
Legislative Counsel’s Digest:
Existing law authorizes a patient who has been diagnosed with a terminal 1
condition to refuse life -resuscitating or life -sustaining treatment in certain 2
circumstances. (NRS 449A.400 -449A.581, 450B.400 -450B.590) Sections 5-33 of 3
this bill authorize a patient, under certain circumstances, to self -administer a 4
medication that is desi gned to end the life of the patient. Section 14 defines 5
“practitioner” to mean a physician, osteopathic physician or advanced practice 6
registered nurse. Sections 6-13, 15 and 16 define other relevant terms. Section 17 7
authorizes a patient to request that his or her attending practitioner prescribe a 8
medication that is designed to end his or her life if the patient: (1) is at least 18 9
years of age; (2) has been diagnosed with a terminal condition by at least two 10
practitioners; (3) has made an informed and voluntary decision to end his or her 11
own life; (4) is mentally capable of making such a decision; and (5) is not 12
requesting the medication because of coercion, deception or undue influence. 13
Section 18 prescribes certain requirements concerning the manner in which a 14
patient may request a medication that is designed to end the life of the patient, 15
including that the patient make two verbal requests and one written request for the 16
medication, and that the written request for the medication be signed by a witness. 17
Section 19 prescribes the form for the written request for the medication. Section 18
20 imposes certain requirements before a practitioner is authorized to prescribe a 19
medication that is designed to end the life of a p atient, including that the 20
practitioner: (1) inform the patient of his or her right to revoke a request for the 21
medication at any time; (2) determine and verify that the patient meets 22
the requirements for making such a request; (3) discuss certain relevant factors with 23
the patient, including the diagnosis and prognosis of the patient and alternative 24
options for care; (4) refer the patient to a consulting practitioner who can confirm 25
the diagnosis, prognosis and mental capability of the patient and that the patient has 26
not been coerced or unduly influenced; and (5) instruct the patient against self -27
administering the medication in public. Section 21 requires a practitioner who 28
determines that a patient who has requested a prescription for a medication that is 29
designed to end his or her life may not be mentally capable to refer the patient to a 30
qualified mental health professional and to receive confirmation about the patient’s 31
mental capability. 32
Section 22: (1) prescribes procedures for the issuance of a pres cription for a 33
medication that is designed to end the life of the patient; and (2) provides that only 34
an attending practitioner or a pharmacist may dispense such a medication. Section 35
22.5 of this bill prescribes the manner in which the attending practitio ner may bill 36
the patient or the insurer of the patient for diagnosing the condition of the patient 37
and prescribing the medication. Section 23 prohibits an attending practitioner from 38
prescribing a medication that is designed to end the life of a patient ba sed solely on 39
the age or disability of the patient. Section 24 requires certain providers of health 40
care to include certain information concerning requests and prescriptions for and 41
the dispensing of a medication that is designed to end the life of a patie nt in the 42
medical record of the patient. If a patient who has requested a medication that is 43
designed to end the life of a patient transfers care to another practitioner or health 44
care facility, sections 24 and 31 require the practitioner or health care fa cility that 45
previously provided care to the patient to forward the patient’s medical records to 46
the new practitioner or health care facility. Section 27 prescribes certain 47
information that must be reported by an attending practitioner to the Division of 48
Public and Behavioral Health of the Department of Health and Human Services 49
relating to a patient who has been prescribed or self -administered such a 50
medication. Section 28 requires the Division to compile an annual report 51
concerning the implementation of th e provisions of this bill authorizing a patient to 52
request a prescription for a medication that is designed to end the life of the patient. 53

– 3 –

- *AB346_R1*
Sections 27, 40 and 43 of this bill provide that such information is otherwise 54
confidential when reported to the Division. 55
Section 25 authorizes a patient, at any time, to revoke a request for a 56
medication that is designed to end his or her life. Sections 26 and 35 of this bill 57
provide that only the patient to whom a medication that is designed to end his or 58
her life is prescribed may administer the medication. Section 26 establishes 59
requirements for the disposal of any unused portion of the medication. 60
Section 33 makes certain persons exempt from professional discipline and 61
immune from civil and criminal penalties and provides that such persons do not 62
violate any applicable standard of care for taking actions authorized by this bill to 63
assist a patient in acquirin g a medication that is designed to end the life of the 64
patient. Section 33.3 of this bill require s a person who administers emergency 65
medical services to treat a prescription for a medication that is designed to end the 66
life of a patient as a written do -not-resuscitate order for the purpose of withholding 67
life-sustaining treatment. Section 33.6 of this bill requires a person who administers 68
emergency medical services who responds to a person who has self -administered a 69
medication that is designed to end his or her life to indicate “medical aid in dying” 70
in any report concerning the incident. Section 33.1 of this bill makes a conforming 71
change to include a patient who has self -administered a medication designed to end 72
his or her life in the definition of “qua lified patient” for the purpose of provisions 73
governing the withholding of life -sustaining treatment. Section 29 provides that a 74
death resulting from the self -administration of a medication that is designed to end 75
the life of a patient is not mercy killing , euthanasia, assisted suicide, suicide or 76
homicide when done in accordance with the provisions of this bill, and section 2 of 77
this bill requires a death certificate to list the terminal condition of the patient as the 78
cause of death of the patient. However, section 1.5 of this bill requires a death 79
certificate to include a box that may be marked to indicate that a patient died from 80
the self-administration of a medication that is designed to end the life of a patient, 81
and section 2 requires the death certif icate of such a patient to indicate that the 82
patient died in that manner through a mark in that box. Sections 1 and 3 of this bill 83
provide that a coroner, coroner’s deputy or local health officer is not required to 84
certify the cause of such a death. Section 42 of this bill: (1) authorizes a coroner to 85
make an appropriate investigation after discovering that a person has self -86
administered a medication designed to end the life of the person, to the extent 87
necessary to determine the cause of the terminal condi tion with which the person 88
was diagnosed; and (2) requires a coroner to cease such an investigation after 89
determining that the terminal condition resulted from a natural cause. Section 41 of 90
this bill makes a conforming change to revise certain internal references. 91
Sections 30 and 38 of this bill prohibit a person from preventing or requiring a 92
person to make or revoke a request for a medication that is designed to end the life 93
of the person as a condition to receiving health care or as a condition in an 94
agreement, contract or will. 95
Section 31 clarifies that a practitioner is not required to prescribe a medication 96
that is designed to end the life of a patient and remains responsible for treating the 97
patient’s pain. However, if a patient who is diagnosed w ith a terminal condition 98
requests information concerning the prescription and self -administration of a 99
medication that is designed to end the life of the patient, section 31 requires a 100
practitioner to provide that information or facilitate the transfer of the patient to 101
another provider of health care. Section 31 also provides that a pharmacist is not 102
required to fill a prescription for or dispense such a medication. Section 32 103
authorizes the owner or operator of a health care facility to prohibit an employ ee or 104
independent contractor of the health care facility or any person who provides 105
services on the premises of the health care facility from providing any services 106
relating to prescribing a medication that is designed to end the life of a patient 107
while acting within the scope of his or her employment or contract with the facility 108

– 4 –

- *AB346_R1*
or while on the premises of the facility. Section 33 prohibits a health care facility or 109
provider of health care from taking certain actions against an employee or 110
independent con tractor who: (1) provides accurate, scientific information 111
concerning end -of-life care to a patient; or (2) facilitates the prescription or self -112
administration of a medication that is designed to end the life of the patient. 113
Sections 34-37 of this bill make conforming changes to clarify that a practitioner or 114
pharmacist is authorized to dispense a medication that is designed to end the life of 115
a patient that is a controlled substance or dangerous drug and a patient may self -116
administer such a medication in a ccordance with other provisions governing 117
medications designed to end the life of a patient. 118
Section 39 of this bill provides that a proposed protected person shall not be 119
deemed to be in need of a general or special guardian solely because the proposed 120
protected person requested a medication that is designed to end his or her life or 121
revoked such a request. 122
Sections 44 and 45 of this bill prohibit insurers from conditioning life 123
insurance benefits, group life insurance benefits or the payment of claims on 124
whether the insured makes, fails to make or revokes a request for a medication that 125
is designed to en d the life of the insured or self -administers such a medication. 126
Section 46 of this bill makes a conforming change to reflect this prohibition on a 127
policy of group life insurance. 128

WHEREAS, A mentally capable adult patient should have the 1
right to self -determination concerning his or her health care 2
decisions based on his or her values, beliefs or personal preferences; 3
and 4
WHEREAS, It is important that patients have the full range of 5
options for their care, especially at the end of their lives; and 6
WHEREAS, Patients with a terminal illness may undergo 7
unremitting pain, agonizing discomfort and a sudden, continuing 8
and irreversible reduction in their quality of life; and 9
WHEREAS, The availability of medical aid in dying provides an 10
additional palliative care option for persons with a terminal illness 11
who seek to retain their autonomy and some level of control over 12
the progression of their disease or ease unnecessary pain and 13
suffering; and 14
WHEREAS, The integration of medical aid in dying into standard 15
end-of-life care has demonstrabl y improved such care by 16
contributing to better conversations between providers of health care 17
and patients, earlier and more appropriate enrollment in hospice care 18
and better training concerning palliative care for providers; and 19
WHEREAS, Patient-directed care respects and responds to the 20
decisions, preferences, needs and values of individual patients, 21
ensures that the values of patients direct all clinical decisions 22
concerning their care and ensures that patients are fully informed of 23
and able to access t he options for care that they desire; now, 24
therefore, 25

– 5 –

- *AB346_R1*
THE PEOPLE OF THE STATE OF NEVADA, REPRESENTED IN 1
SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS: 2
3
Section 1. Chapter 440 of NRS is hereby amend ed by adding 4
thereto a new section to read as follows: 5
1. A coroner, coroner’s deputy or local health officer is not 6
required to certify the cause of death of a patient who dies after 7
self-administering a medication that is designed to end the life of 8
the patient in accordance with the provisions of sections 5 to 33, 9
inclusive, of this act. 10
2. A coroner, coroner’s deputy or local health officer may 11
access any records or information submitted to the Division of 12
Public and Behavioral Health of the Department of Health and 13
Human Services pursuant to section 27 of this act to confirm that 14
a patient died from self -administering a medication that is 15
designed to end the life of the patient in accordance with the 16
provisions of sections 5 to 33, inclusive, of this act. 17
Sec. 1.5. NRS 440.350 is hereby amended to read as follows: 18
440.350 [The] 19
1. Except as otherwise provided in subsection 2, the certificate 20
of death or of stillbirth that shall be used is the standard form 21
approved by the United States Public Health Service. 22
2. The certificate of death must contain a box that may be 23
marked to indicate that a patient die d after self -administering a 24
medication that is designed to end his or her life in accordance 25
with sections 5 to 33, inclusive, of this act. 26
Sec. 2. NRS 440.380 is hereby amended to read as follows: 27
440.380 1. The medical certificate of death must be signed 28
by the physician or advanced practice registered nurse, if any, last in 29
attendance on the deceased, or pursuant to regula tions adopted by 30
the Board, it may be signed by the attending physician’s associate 31
physician, the chief medical officer of the hospital or institution in 32
which the death occurred, or the pathologist who performed an 33
autopsy upon the deceased. The person w ho signs the medical 34
certificate of death shall specify: 35
(a) The social security number of the deceased. 36
(b) The hour and day on which the death occurred. 37
(c) The cause of death, so as to show the cause of disease or 38
sequence of causes resulting in deat h, giving first the primary cause 39
of death or the name of the disease causing death, and the 40
contributory or secondary cause, if any, and the duration of each. 41
2. In deaths in hospitals or institutions, or of nonresidents, the 42
physician or advanced pract ice registered nurse shall furnish the 43
information required under this section, and may state where, in his 44
or her opinion, the disease was contracted. 45

– 6 –

- *AB346_R1*
3. The medical certificate of death of a patient who dies after 1
self-administering a medication that is designed to end the life of 2
the patient in accordance with sections 5 to 33, inclusive, of this 3
act: 4
(a) Must specify the terminal condition with which the patient 5
was diagnosed as the cause of death; 6
(b) Must not indicate suicide as the cause of death; and 7
(c) Must indicate that the patient died after self -administering 8
a medication that is designed to end his or her life through a mark 9
in the box included in the certificate of death pursuant to 10
subsection 2 of NRS 440.350. 11
Sec. 3. NRS 440.420 is hereby amended to read as follows: 12
440.420 1. In case of any death occ urring without medical 13
attendance, the funeral director shall notify the local health officer, 14
coroner or coroner’s deputy of such death and refer the case to the 15
local health officer, coroner or coroner’s deputy . [for immediate 16
investigation and certific ation.] Except as otherwise provided in 17
NRS 259.050 and section 1 of this act, the coroner, coroner’s 18
deputy or local health officer shall immediately investigate the 19
death and certify the cause of death. 20
2. Where there is no qualified physician or advanced practice 21
registered nurse in attendance, and in such cases only, the local 22
health officer is authorized to make the certificate and return from 23
the statements of relatives or other persons having adequate 24
knowledge of the facts. 25
3. If the death was caused by unlawful or suspicious means, the 26
local health officer shall then refer the case to the coroner for 27
investigation and certification. 28
4. In counties which have adopted an ordinance authorizing a 29
coroner’s examination in cases of sudden infant death syndrome, the 30
funeral director shall notify the local health officer whenever the 31
cause or suspected cause of death is sudden infant death syndrome. 32
The local health officer shall then refer the case to the coroner for 33
investigation and certification. 34
5. The coroner or the coroner’s deputy may certify the cause of 35
death in any case which is referred to the coroner by the local health 36
officer or pursuant to a local ordinance. 37
Sec. 4. Chapter 449A of NRS is hereby am ended by adding 38
thereto the provisions set forth as sections 5 to 33, inclusive, of this 39
act. 40
Sec. 5. As used in sections 5 to 33, inclusive, of this act, 41
unless the context otherwise requires, the words and terms defined 42
in sections 6 to 16, inclusive, of this act have the meanings 43
ascribed to them in those sections. 44

– 7 –

- *AB346_R1*
Sec. 6. “Advanced practice regis tered nurse” means a 1
registered nurse who holds a valid license as an advanced practice 2
registered nurse issued by the State Board of Nursing pursuant to 3
NRS 632.237. 4
Sec. 7. “Attending practitioner” means the practitioner who 5
has primary responsibility for the treatment of a terminal 6
condition from which a patient suffers. 7
Sec. 8. “Consulting practitioner” means a practitioner to 8
whom a patient is referred pursuant to paragraph (d) of subsection 9
1 of section 20 of this act for confirmation of the diagnosis and 10
prognosis of the patient and that the patient meets the 11
requirements of subsections 3, 4 and 5 of section 17 of this act. 12
Sec. 9. “Division” means the D ivision of Public and 13
Behavioral Health of the Department of Health and Human 14
Services. 15
Sec. 10. “Health care facility” means any facility licensed 16
pursuant to chapter 449 of NRS. 17
Sec. 11. “Mentally capable” means that a patient has the 18
ability to make, communicate and understand the nature and 19
consequences of the decision to request and self -administer a 20
medication that is designed to end the life of the patient. 21
Sec. 12. “Person professionally qualified in the field of 22
psychiatric mental health” means: 23
1. A psychiatrist licensed to practice medicine in the State of 24
Nevada and certified by the American Board of Psychiatry and 25
Neurology; 26
2. A psychologist licensed to practice in this State; 27
3. A social worker who holds a master’s degree in social 28
work, is licensed by the State as a clinical social worker and is 29
employed by the Division; 30
4. A registered nurse who: 31
(a) Is licensed to practice professiona l nursing in this State; 32
and 33
(b) Holds a master’s degree in the field of psychiatric nursing; 34
and 35
(c) Is employed by the Division; and 36
5. A clinical professional counselor licensed pursuant to 37
chapter 641A of NRS. 38
Sec. 13. “Physician” means a person who is licensed to 39
practice medicine pursuant to chapter 630 of NRS or osteopathic 40
medicine pursuant to chapter 633 of NRS. 41
Sec. 14. “Practitioner” means a physician or advanced 42
practice registered nurse. 43
Sec. 15. “Self-administer” or “self -administration” means 44
the ingestion by a person of a medication that is designed to end 45

– 8 –

- *AB346_R1*
his or her life as an affirmative, conscious and voluntary act. The 1
term does not include the administration of the medication by 2
parenteral injection or infusion. 3
Sec. 16. “Terminal condition” means an incurable and 4
irreversible condition that will, in accordance with reasonable 5
medical judgment, result in death within 6 months. 6
Sec. 17. A patient may request that his or her attending 7
practitioner prescribe a medication that is designed to end the life 8
of the patient if the patient: 9
1. Is at least 18 years of age; 10
2. Has been diagnosed with a terminal condition by the 11
attending practitioner and at least one consulting practitioner; 12
3. Has made an informed and voluntary decision to end his 13
or her own life; 14
4. Is mentally capable; and 15
5. Is not requesting th e medication because of coercion, 16
deception or undue influence. 17
Sec. 18. 1. A patient who wishes to obtain a prescription for 18
a medication that is designed to end his or her life must: 19
(a) Make two verbal requests for th e medication to his or her 20
attending practitioner. Except as otherwise provided in this 21
paragraph, the second verbal request must be made at least 15 22
days after the first verbal request. If the attending practitioner 23
determines that the patient is reasonab ly likely to die within 15 24
days after the first verbal request, the patient may make the second 25
verbal request at any time. 26
(b) Make a written request for the medication in the form 27
prescribed by section 19 of this act and submit the written request 28
to th e attending practitioner. The written request for the 29
medication must be signed by the patient and one witness, who 30
must not be: 31
(1) Related to the patient by blood, marriage or adoption; 32
(2) Entitled to any portion of the estate of the patient upon 33
death under a will or by operation of law; 34
(3) An owner, operator or employee of a health care facility 35
where the patient is receiving treatment or is a resident; 36
(4) The attending practitioner; or 37
(5) An interpreter for the patient. 38
2. An oral or written request made pursuant to this section 39
may not be made: 40
(a) By any person acting on behalf of the patient, including, 41
without limitation, a surrogate, supporter, guardian or person 42
designated in a power of attorney to make decisions concerning 43
health care pursuant to NRS 162A.790. 44
(b) In an advance directive. 45

– 9 –

- *AB346_R1*
3. As used in this section: 1
(a) “Advance directive” has the meaning ascribed to it in 2
NRS 449A.703. 3
(b) “Supporter” has the meaning ascribed to it in 4
NRS 162C.090. 5
Sec. 19. A written request for a medication that is designed to 6
end the life of a patient must be in substantially the following 7
form: 8
9
REQUEST FOR A MEDICATION 10
THAT IS DESIGNED TO END MY LIFE 11
12
I, ....................................., am an adult of sound mind. 13
14
I have been diagnosed with .............................................. 15
and given a prognosis of less than 6 months to live. 16
17
I have been fully informed of my diagnosis, my 18
prognosis an d the feasible alternative, concurrent or 19
additional treatment opportunities, including comfort care, 20
hospice care and pain control. I have been offered resources 21
or referrals to pursue these alternative, concurrent or 22
additional treatment opportunities. 23
24
I have been fully informed of the nature of the 25
medication to be prescribed to me and the risks and benefits 26
of self -administering the medication, including that the 27
likely effect of self -administering the medication is death. I 28
understand that I can resc ind this request at any time and 29
that I am under no obligation to fill the prescription once it 30
is written or to self-administer the medication if I obtain it. 31
32
I request that my attending practitioner prescribe a 33
medication that I may self -administer to end my life and 34
authorize my attending practitioner to contact a pharmacist 35
to fill the prescription at a time of my choosing. 36
37
I make this request voluntarily, free from coercion or 38
undue influence. 39
40
Signed: .......................................................................... 41
42
Dated: ............................................................................ 43
44
Witness signature: ........................................................ 45

– 10 –

- *AB346_R1*
Date: .............................................................................. 1
Sec. 20. 1. Before prescribing a medication that is designed 2
to end the life of a patient, the attending practitioner of the patient 3
must: 4
(a) Inform the patient that he or she may revoke a request for 5
the medication at a ny time and provide the patient with the 6
opportunity to revoke his or her second verbal request made 7
pursuant to subsection 1 of section 18 of this act; 8
(b) Determine and verify, after each verbal and written request 9
for the medication made pursuant to subsection 1 of section 18 of 10
this act and immediately before writing the prescription, that the 11
patient meets the requirements of subsections 3, 4 and 5 of section 12
17 of this act; 13
(c) Discuss with the patient: 14
(1) The diagnosis and prognosis of the patient; 15
(2) All available methods of treating or managing the 16
terminal condition of the patient, including, without limitation, 17
comfort care, hospice care and pain control, and the risks and 18
benefits of each method; 19
(3) The risks and benefits of self -administering the 20
medication, including, without limitation, that death is the 21
probable result of self-administering the medication; 22
(4) The recommended procedure for self -administering the 23
medication; 24
(5) The manner in which the medication must be kept and 25
disposed of in accordance with applicable state and federal law; 26
(6) The importance of having another person present when 27
the patient self-administers the medication; and 28
(7) The benefits of notifying the patient’s next of kin of his 29
or her decision to request a prescriptio n for a medication that is 30
designed to end the life of the patient; 31
(d) Refer the patient to a consulting practitioner who is 32
qualified by reason of specialty or experience to diagnose the 33
terminal condition of the patient for examination and receive 34
written confirmation from that practitioner of the diagnosis and 35
prognosis of the patient and that the patient meets the 36
requirements of subsections 3, 4 and 5 of section 17 of this act; 37
(e) Inform the patient that there is no obligation to fill the 38
prescription or to self-administer the medication, if obtained; and 39
(f) Instruct the patient against self -administering the 40
medication in a public place. As used in this paragraph, “public 41
place” means any location readily accessible to the general public, 42
but does not include a health care facility. 43

– 11 –

- *AB346_R1*
2. The attending practitioner shall refer the patient for 1
comfort care, palliative care, hospice care, pain control or other 2
end-of-life care if requested or as clinically indicated. 3
Sec. 21. 1. If the attending practitioner to whom a patient 4
makes a request for a medication that is designed to end the life of 5
the patient or the consulting practitioner to whom a patient is 6
referred pursuant to paragraph (d) of subsection 1 of section 20 of 7
this act determines that the patient may not be mentally capable: 8
(a) The attending practitioner or consulting practitioner, as 9
applicable, must refer the patient for examination by a person 10
professionally qualified in the field of psychiatric ment al health; 11
and 12
(b) The attending practitioner must not prescribe a medication 13
that is designed to end the life of the patient, unless the person 14
professionally qualified in the field of psychiatric mental health 15
concludes, based on the examination, that the patient is mentally 16
capable. 17
2. If a patient is examined pursuant to subsection 1, the 18
person professionally qualified in the field of psychiatric mental 19
health must provide to the attending practitioner and, if 20
applicable, the consulting practitione r who made the referral, his 21
or her written determination regarding whether the patient is 22
mentally capable. 23
Sec. 22. 1. Except as otherwise provided in section 23 of 24
this act, the attending practitioner of a patient may prescribe a 25
medication that is designed to end the life of the patient after the 26
attending practitioner has ensured that the requirements of 27
sections 17 to 21, inclusive, of this act have been met. 28
2. After an attending practitioner prescribes a medication 29
that is designed to end the life of a patient, the attending 30
practitioner shall, after obtaining the written consent of the 31
patient, contact a pharmacist and inform the pharmacist of the 32
prescription. After the pharmacist has been notified, the attending 33
practitioner shall transmit the prescription directly to the 34
pharmacist. 35
3. A medication that is designed to end the life of a patient 36
may only be dispensed by a registered pharmacist or by th e 37
attending practitioner of the patient. A pharmacist may only 38
dispense such a medication pursuant to a valid prescription 39
provided by an attending practitioner in accordance with 40
subsection 2 to: 41
(a) The patient; 42
(b) The attending practitioner who pre scribed the medication; 43
or 44

– 12 –

- *AB346_R1*
(c) An agent of the patient who has been expressly identified to 1
the pharmacist as such by the patient. 2
Sec. 22.5. When billing a patient or his or her insurer for 3
services in connection with prescribing a medication that is 4
designed to end the life of the patient, an attending practitioner 5
may only bill the patient or his or her insurer using the 6
appropriate coding found in the current edition of the Current 7
Procedural Terminology published by the American Medical 8
Association for: 9
1. Diagnosing the patient; and 10
2. Prescribing the medication that is designed to end the life 11
of the patient. 12
Sec. 23. An attending practitioner shall not prescribe a 13
medication that is designed to end the life of a patient based solely 14
on the age or disability of the patient. 15
Sec. 24. 1. The attending practitioner of a patient who 16
requests a medication that is designed to end the life of the patien t 17
shall document in the medical record of the patient: 18
(a) Each request for such a medication made by the patient, 19
including, without limitation, by including in the record a copy of 20
the written request submitted pursuant to paragraph (b) of 21
subsection 1 of section 18 of this act, and each revocation of such 22
a request; 23
(b) The diagnosis and the prognosis of the patient provided by 24
the attending practitioner; 25
(c) Each determination made by the attending practitioner 26
concerning whether the patient meets the requirement s of 27
subsections 3, 4 and 5 of section 17 of this act; 28
(d) Confirmation that: 29
(1) The attending practitioner offered the patient the 30
opportunity to revoke his or her second verbal request for the 31
medication, as required by subsection 1 of section 20 of this act; 32
and 33
(2) The requirements set forth in sections 5 to 33, inclusive, 34
of this act have been satisfied; and 35
(e) The name, amount and dosage of any medication that is 36
designed to end the life of the patient and any ancillary 37
medications that the at tending practitioner prescribes for the 38
patient. 39
2. A consulting practitioner shall report to the attending 40
practitioner of the patient and document in the medical record of 41
the patient his or her: 42
(a) Confirmation that the patient has requested a medic ation 43
designed to end the life of the patient; 44

– 13 –

- *AB346_R1*
(b) Diagnosis and opinion regarding the prognosis of the 1
patient; and 2
(c) Determination concerning whether the patient meets the 3
requirements of subsections 3, 4 and 5 of section 17 of this act. 4
3. A person professionally qualified in the field of psychiatric 5
mental health to whom a patient is referred pursuant to section 21 6
of this act shall document in the medical record of the patient his 7
or her determination of whether the patient is mentally capable. 8
4. If a patient who has requested a medication that is 9
designed to end his or her life changes his or her attending 10
practitioner or transfers his or her care to a different health care 11
facility, the prior attending practitioner and health care facility, a s 12
applicable, must, upon the request of the patient or the new 13
attending practitioner or health care facility, forward the medical 14
records of the patient to the new attending practitioner or health 15
care facility, as applicable. 16
Sec. 25. 1. A patient who requests a medication that is 17
designed to end his or her life may revoke the request at any time, 18
without regard to his or her age or physical or mental condition. 19
2. The revocation of a request for such a medication beco mes 20
effective immediately upon the patient communicating the 21
revocation to his or her attending practitioner. When the patient 22
revokes such a request, the attending practitioner must document 23
the revocation in the medical record of the patient. 24
Sec. 26. 1. Only a patient to whom a medication that is 25
designed to end his or her life is prescribed may administer the 26
medication. No other person may administer the medication to the 27
patient, including, without limitation, by pare nteral injection or 28
infusion. Any person who is present may assist the patient in 29
preparing the medication for self-administration. 30
2. If any amount of a medication that is designed to end the 31
life of a patient is not self -administered, it must be dispos ed of in 32
accordance with law. 33
Sec. 27. 1. An attending practitioner who prescribes a 34
medication that is designed to end the life of a patient shall: 35
(a) Not more than 30 days after prescribing the medication, 36
provide to the Division in the form prescribed by the Division the 37
name, date of birth, diagnosis and prognosis of the patient and 38
affirmation that the prescription was issued in accordance with 39
the provisions of sections 5 to 33, inclusive, of this act; and 40
(b) Not more than 60 days after the death of a patient from 41
administering the medication, provide to the Division the name 42
and date of birth of the patient, the date on which the patient died 43
and a statement of whether the patient was receiving hospice care 44
at the time of death. 45

– 14 –

- *AB346_R1*
2. The Division shall prescribe forms for reporting each set of 1
information required by subsection 1. 2
3. Except as otherwise provided in NRS 239.0115 and 3
sections 1 and 28 of this act, any information or records submitted 4
to the Division pursuant to this section are confidential. 5
4. The Division shall annually review a sample of the reports 6
submitted pursuant to subsection 1 to ensure compliance with the 7
requirements of that subsection. 8
5. The provisions of subsection 1 of section 33 of this act do 9
not apply to a practitioner who willfully fails to comply with the 10
requirements of this section. 11
Sec. 28. On or before February 1 of each year, the Division 12
shall: 13
1. Compile a report concerning the imp lementation of the 14
provisions of sections 5 to 33, inclusive, of this act. The report: 15
(a) Must include, for the immediately preceding calendar year: 16
(1) The number of patients to whom a medication that is 17
designed to end the life of a patient was prescribed; 18
(2) The number of patients described in subparagraph (1) 19
who died after self -administering the medication and the terminal 20
conditions which were specified as the cause of those deaths; and 21
(3) The number of practitioners who prescribed a 22
medication that is designed to end the life of a patient. 23
(b) Must not include the personally identifiable information of 24
any patient or provider of health care. 25
2. Make the report compiled pursuant to subsection 1 publicly 26
available on the Internet website maintained by the Division. 27
Sec. 29. 1. A death resulting from a patient self -28
administering a medication that is designed to end his or her life 29
in accordance with the provisions of sections 5 to 33, inclusive, of 30
this act does not constitute mercy killing, euthanasia, assisted 31
suicide, suicide or homicide. 32
2. Any report or other document produced by this State, any 33
political subdivision of this State or any agency, board, 34
commission, department, officer, employee o r agent of this State 35
must refer to a request for, acquisition of, prescription of, 36
dispensing of and self -administration of a medication that is 37
designed to end the life of a patient as a request for, acquisition of, 38
prescription of, dispensing of and sel f-administration, as 39
applicable, of a medication that is designed to end the life of a 40
patient. 41
Sec. 30. 1. A person shall not prevent a patient from 42
making or revoking or require a patient to make or revoke a 43
request for a medication that is designed to end the life of the 44
patient as a condition of receiving health care. 45

– 15 –

- *AB346_R1*
2. Any provision in any contract or agreement entered into 1
before, on or after the effective date of this act, whether written or 2
oral, that would affe ct the right of a patient to take any action in 3
accordance with the provisions of sections 5 to 33, inclusive, of 4
this act is unenforceable and void. 5
Sec. 31. 1. The provisions of sections 5 to 33, inclusive, of 6
this act do not: 7
(a) Require an attending practitioner to prescribe a medication 8
that is designed to end the life of a patient or require a pharmacist 9
to fill a prescription for or dispense such a medication; 10
(b) Affect the responsibility of a practitioner to prov ide 11
information and treatment in accordance with the standard of 12
care, including, without limitation, treatment for a patient’s 13
comfort or alleviation of pain; or 14
(c) Condone, authorize or approve mercy killing, euthanasia 15
or assisted suicide. 16
2. An at tending practitioner shall provide a patient who is 17
diagnosed with a terminal condition with complete and accurate 18
information concerning his or her available options for care and 19
the risks and benefits of each option. If an attending practitioner 20
is unwil ling or unable to provide information concerning the 21
prescription and self -administration of a medication that is 22
designed to end the life of the patient in accordance with sections 23
5 to 33, inclusive, of this act to a patient who requests such 24
information, the attending practitioner must facilitate the 25
transition of the patient to another provider of health care, unless 26
the patient refuses such a transition. An attending practitioner 27
who fails to comply with the requirements of this subsection shall 28
be deemed to have failed to obtain informed consent to any care 29
provided to the patient after the request. 30
3. If a patient requests pursuant to section 18 of this act that 31
the attending practitioner prescribe a medication that is designed 32
to end the life of th e patient and the attending practitioner is 33
unwilling or unable to issue a prescription for such medication, 34
the attending practitioner shall: 35
(a) Document the request and the date of the request in the 36
medical record of the patient; and 37
(b) Upon request, forward the medical records of the patient as 38
required by subsection 4 of section 24 of this act. 39
Sec. 32. 1. Except as otherwise required by section 31 of 40
this act, the owner or operator of a health care facility may 41
prohibit: 42
(a) Any employee or independent contractor of the health care 43
facility from providing any services described in sections 5 to 33, 44
inclusive, of this act while acting within the scope of his or her 45

– 16 –

- *AB346_R1*
employment or contract, as applicable, with the h ealth care 1
facility; or 2
(b) Any other person, including, without limitation, an 3
employee or independent contractor of the health care facility or 4
another provider of health care who provides services on the 5
premises of the health care facility, from prov iding any services 6
described in sections 5 to 33, inclusive, of this act on the premises 7
of the health care facility. 8
2. An owner or operator of a health care facility who 9
prohibits any person from providing services described in sections 10
5 to 33, inclusive, of this act shall provide notice of the prohibition 11
to: 12
(a) Each employee and independent contractor of the health 13
care facility at the time of hiring and annually thereafter; and 14
(b) Each provider of health care not described in paragraph 15
(a) who provides services on the premises of the health care 16
facility, including, without limitation, through telehealth as 17
defined in NRS 629.515, at the time the provider of health care 18
begins providing services on the premises of the health care 19
facility and annually thereafter. 20
3. The owner or operator of a health care facility may take 21
any action authorized by law or authorized pursuant to any 22
applicable rule, policy, procedure or contract against any person 23
who provides a service prohibited by the owner or operator in 24
compliance with subsection 1 while acting within the scope of his 25
or her employment or contract, as applicable, or on the premises 26
of the health care facility. 27
Sec. 33. 1. Except as otherwise provided in section 32 of 28
this act: 29
(a) A health care facility or provider of health care shall not: 30
(1) Prohibit an employee or independent contractor from: 31
(I) Providing services described in sections 5 to 33, 32
inclusive, of this act outside the scope of th e employment or 33
contract, as applicable, and off the premises of the health care 34
facility or any premises owned or operated by the provider of 35
health care; 36
(II) Being present when a patient self -administers a 37
medication that is designed to end the life of the patient outside the 38
scope of his or her employment or contract, as applicable, and off 39
the premises of the health care facility or any premises owned or 40
operated by the provider of health care; or 41
(III) Providing accurate, scientific information 42
concerning the diagnosis and prognosis of a patient or options for 43
the treatment of a terminal condition, including, without 44
limitation, the administration of a medication that is designed to 45

– 17 –

- *AB346_R1*
end the life of a patient, or providing information concerning 1
available health care services and other resources, including, 2
without limitation, information about how to access such services 3
and resources, when discussing the options of the patient for end -4
of-life care; or 5
(2) Discharge, demote, censure, suspend, revoke or suspend 6
the privileges of, discipline or otherwise penalize an employee or 7
independent contractor who takes any action described in 8
subparagraph (1). 9
(b) A practitioner, person professionally qualified in the field 10
of psychiatric mental health, pharmacist or other provider of 11
health care is not subject to professional discipline, does not 12
violate any applicable standard of care and is not subject to any 13
civil or criminal penalty solely because the provider of health care: 14
(1) Takes any action a uthorized by sections 5 to 33, 15
inclusive, of this act, including, without limitation, assisting a 16
patient in preparing a medication that is designed to end the life of 17
the patient in accordance with subsection 1 of section 26 of this 18
act; or 19
(2) Is present when a patient self -administers a medication 20
that is designed to end the life of the patient or when a patient dies 21
as a result of such self-administration. 22
(c) A health care facility is not subject to disciplinary action, 23
does not violate any applicab le standard of care and is not subject 24
to any civil or criminal penalty solely because an employee or 25
independent contractor of the health care facility takes any action 26
authorized by sections 5 to 33, inclusive, of this act. 27
(d) A person other than a provider of health care is not subject 28
to professional discipline, does not violate any applicable standard 29
of care and is not subject to any civil or criminal penalty solely 30
because the person: 31
(1) Assists a patient in preparing a medication that is 32
designed to end the life of the patient in accordance with 33
subsection 1 of section 26 of this act; or 34
(2) Is present when a patient self -administers a medication 35
that is designed to end the life of the patient or when a patient dies 36
as a result of such self-administration. 37
2. If any part of paragraph (a) of subsection 1 conflicts with 38
requirements concerning the receipt of federal money by this 39
State, the conflicting provision does not apply solely to the extent 40
of the conflict with respect to the health care facility or provider of 41
health care directly affected. 42
3. A local government, coroner, law enforcement agency or 43
an employee of a local government, coroner or law enforcement 44
agency is not subject to any civil or criminal penalty for ceasing or 45

– 18 –

- *AB346_R1*
refusing to investigate or take other action in response to a death 1
resulting from the self -administration of a medication designed to 2
end the life of the patient pursuant to sections 5 to 33, inclusive, of 3
this act or refusing to make a finding concerning such a death. 4
4. The provisions of this section do not limit liability for 5
damages resulting from the negligence or intentional misconduct 6
of any person providing services pursuant to sections 5 to 33, 7
inclusive, of this act. 8
Sec. 33.1. NRS 450B.470 is hereby amended to read as 9
follows: 10
450B.470 “Qualified patient” means: 11
1. A patient 18 years of age or older who has been determined 12
by the patient’s attending physician or attending advanced practice 13
registered nurse to be in a terminal condition and who: 14
(a) Has executed a declaration in accordance with the 15
requirements of NRS 449A.433; 16
(b) Has executed a Provider Order for Life -Sustaining 17
Treatment form pursuant to NRS 449A.500 to 449A.581, inclusive, 18
if the form provide s that the patient is not to receive life -19
resuscitating treatment; [or] 20
(c) Has been issued a do -not-resuscitate order pursuant to NRS 21
450B.510 [.] ; or 22
(d) Has self-administered a medication that is designed to end 23
his or her life in accordance with sections 5 to 33, inclusive, of this 24
act. 25
2. A patient who is less than 18 years of age and who: 26
(a) Has been determined by the patient’s attending physician or 27
attending advanced practice registered nurse to be in a terminal 28
condition; and 29
(b) Has execut ed a Provider Order for Life -Sustaining 30
Treatment form pursuant to NRS 449A.500 to 449A.581, inclusive, 31
if the form provides that the patient is not to receive life -32
resuscitating treatment or has been issued a do -not-resuscitate order 33
pursuant to NRS 450B.510. 34
Sec. 33.3. NRS 450B.550 is hereby amended to read as 35
follows: 36
450B.550 1. Except as otherwise provided in subsection 2, a 37
person who administers emergency medical services shall comply 38
with do-not-resuscitate protocol when the person observes a do -not-39
resuscitate identification or carries out a do-not-resuscitate order. 40
2. A person who administers emergency medical services and 41
who is unwilling or unable to comply with the do -not-resuscitate 42
protocol shall ta ke all reasonable measures to transfer a qualified 43
patient who possesses a do-not-resuscitate identification or has been 44
issued a do -not-resuscitate order to a physician, advanced practice 45

– 19 –

- *AB346_R1*
registered nurse or health care facility in which the do -not-1
resuscitate protocol may be followed. 2
3. A prescription for a medication that is designed to end the 3
life of the patient issued in accordance with section s 5 to 33, 4
inclusive, of this act shall be considered a written do -not-5
resuscitate order for the purposes of NRS 450B.400 to 450B.590, 6
inclusive, if a person who administers emergency medical 7
services: 8
(a) Responds to a p atient who has self-administered a 9
medication that is designed to end his or her life; and 10
(b) Determines that such a prescription has been issued to the 11
patient. 12
Sec. 33.6. NRS 450B.570 is hereby amended to read as 13
follows: 14
450B.570 1. Death that results when life -resuscitating 15
treatment has been withheld pursuant to the do -not-resuscitate 16
protocol and in accordance with the provisions of NRS 450B.400 to 17
450B.590, inclusive, does not constitute a suicide or homicide. 18
2. The possession of a do -not-resuscitate identification or the 19
issuance of a do -not-resuscitate order does not affect the sale, 20
procurement or issuance of a policy of life insurance or an annuity 21
or impair or modify the terms of a policy of life insurance or an 22
annuity. A policy of life insurance or an annuity is not legally 23
impaired or invalidated if life -resuscitating treatment has been 24
withheld from an insured who possesses a do -not-resuscitate 25
identification or has been issued a do -not-resuscitate order, 26
notwithstanding any term in the policy or annuity to the contrary. 27
3. A person may not prohibit or require the possession of a do -28
not-resuscitate identification or the issuance of a do -not-resuscitate 29
order as a condition of being insured for, or receiving, health care. 30
4. A person who administers emergency medical services and 31
responds to a p atient who has self-administered a medication that 32
is designed to end the life of the patient in accordance with 33
sections 5 to 33, inclusive, of this act shall indicate “medical aid in 34
dying” in any report concerning the incident created by the person 35
who administers emergency medical services. 36
Sec. 34. NRS 453.256 is hereby amended to read as follows: 37
453.256 1. A prescription for a controlled substance must be 38
given to a pharmacy in compliance with NRS 639.23535. A 39
prescription for a substance included in schedule II must not be 40
refilled. A prescription for a substance included in schedule III or IV 41
which is a dangerous drug as determined under NRS 454.201 must 42
not be filled or refilled more than 6 months after the date thereof or 43
be refilled more than five times, unless renewed by the practitioner. 44

– 20 –

- *AB346_R1*
2. A substance included in schedule V may be distributed or 1
dispensed only for a medical purpose, including medical treatment 2
or authorized research. 3
3. A practitioner may dispense or deliver a controlled 4
substance to or for a person or animal only for medical treatment or 5
authorized research in the ordinary course of his or her profession. 6
4. No civil or criminal liability or administrative sanction may 7
be imposed on a pharmacist for action taken in good faith in reliance 8
on a reasonable belief that an order purporting to be a prescription 9
was issued by a practitioner in the usual course of professional 10
treatment or in authorized research. 11
5. An individual practitioner may not dispense a substance 12
included in schedule II, III or IV for the practitioner’s own personal 13
use except in a medical emergency. 14
6. A person who violates this section is guilty of a category E 15
felony and shall be punished as provided in NRS 193.130. 16
7. As used in this section, “medi cal treatment” includes 17
[dispensing] : 18
(a) Dispensing or administering a narcotic drug for pain, 19
whether or not intractable [.] ; and 20
(b) Dispensing a medication that is designed to end the life of a 21
patient pursuant to the provisions of sections 5 to 33, inclusive, of 22
this act. 23
Sec. 35. NRS 453.375 is hereby amended to read as follows: 24
453.375 1. [A] Except as otherwise provided in sections 5 to 25
33, inclusive, of this act, a controlled substance may be possessed 26
and administered by the following persons: 27
(a) A practitioner. 28
(b) A registered nurse licensed to practice professional nursing 29
or licensed practical nurse, at the direction of a physician, physician 30
assistant, dentist, podiatric physician or advanced practice registered 31
nurse, or pursuant to a chart order, for administration to a patient at 32
another location. 33
(c) A paramedic: 34
(1) As authorized by regulation of: 35
(I) The State Board of Health in a county whose 36
population is less than 100,000; or 37
(II) A county or district board of health in a county whose 38
population is 100,000 or more; and 39
(2) In accordance with any applicable regulations of: 40
(I) The State Board of Health in a county whose 41
population is less than 100,000; 42
(II) A county board of h ealth in a county whose 43
population is 100,000 or more; or 44

– 21 –

- *AB346_R1*
(III) A district board of health created pursuant to NRS 1
439.362 or 439.370 in any county. 2
(d) A respiratory therapist, at the direction of a physician or 3
physician assistant. 4
(e) An anesthesiologist assistant, at the direction of a 5
supervising anesthesiologist or supervising osteopathic 6
anesthesiologist. 7
(f) A medical student, student in training to become a physician 8
assistant or anesthesiologist assistant, student nurse in the cour se of 9
his or her studies at an accredited college of medicine or approved 10
school of professional or practical nursing, at the direction of a 11
physician or physician assistant and: 12
(1) In the presence of a physician, physician assistant or a 13
registered nurse; or 14
(2) Under the supervision of a physician, physician assistant 15
or a registered nurse if the student is authorized by the college or 16
school to administer the substance outside the presence of a 17
physician, physician assistant or nurse. 18
 A medical st udent or student nurse may administer a controlled 19
substance in the presence or under the supervision of a registered 20
nurse alone only if the circumstances are such that the registered 21
nurse would be authorized to administer it personally. 22
(g) An ultimate user or any person whom the ultimate user 23
designates pursuant to a written agreement. 24
(h) Any person designated by the head of a correctional 25
institution. 26
(i) A veterinary technician at the direction of his or her 27
supervising veterinarian. 28
(j) In accordance with applicable regulations of the State Board 29
of Health, an employee of a residential facility for groups, as 30
defined in NRS 449.017, pursuant to a written agreement entered 31
into by the ultimate user. 32
(k) In accordance with applicable regulations o f the State Board 33
of Pharmacy, an animal control officer, a wildlife biologist or an 34
employee designated by a federal, state or local governmental 35
agency whose duties include the control of domestic, wild and 36
predatory animals. 37
(l) A person who is enrolle d in a training program to become a 38
paramedic, respiratory therapist or veterinary technician if the 39
person possesses and administers the controlled substance in the 40
same manner and under the same conditions that apply, respectively, 41
to a paramedic, respir atory therapist or veterinary technician who 42
may possess and administer the controlled substance, and under the 43
direct supervision of a person licensed or registered to perform the 44
respective medical art or a supervisor of such a person. 45

– 22 –

- *AB346_R1*
(m) A registered pharmacist pursuant to written guidelines and 1
protocols developed pursuant to NRS 639.2629 or a collaborative 2
practice agreement, as defined in NRS 639.0052. 3
2. As used in this section: 4
(a) “Accredited college of medicine” means: 5
(1) A medical school that is accredited by the Liaison 6
Committee on Medical Education of the American Medical 7
Association and the Association of American Medical Colleges or 8
their successor organizations; or 9
(2) A school of osteopathic medicine, as defined in 10
NRS 633.121. 11
(b) “Anesthesiologist assistant” means a person who holds a 12
license issued pursuant to NRS 630.2683 or 633.4254 or a 13
temporary license issued pursuant to NRS 630.2685 or 633.4262. 14
Sec. 36. NRS 454.213 is hereby amended to read as follows: 15
454.213 1. Except as otherwise provided in NRS 454.217 [,] 16
and sections 5 to 33, inclusive, of this act, a drug or medicine 17
referred to in NRS 454.181 to 454.371, inclusive, may be possessed 18
and administered by: 19
(a) A practitioner. 20
(b) A physician assistant licensed pursuant to chapter 630 or 633 21
of NRS or an anesthesiologist assistant, at the direction of his or her 22
supervising physician or supervising anesthesiologist or supervising 23
osteopathic anesthesiologist, as applicable, or a l icensed dental 24
hygienist or expanded function dental assistant acting in the office 25
of and under the supervision of a dentist. 26
(c) Except as otherwise provided in paragraph (d), a registered 27
nurse licensed to practice professional nursing or licensed prac tical 28
nurse, at the direction of a prescribing physician, physician assistant 29
licensed pursuant to chapter 630 or 633 of NRS, dentist, podiatric 30
physician or advanced practice registered nurse, or pursuant to a 31
chart order, for administration to a patient at another location. 32
(d) In accordance with applicable regulations of the Board, a 33
registered nurse licensed to practice professional nursing or licensed 34
practical nurse who is: 35
(1) Employed by a health care agency or health care facility 36
that is author ized to provide emergency care, or to respond to the 37
immediate needs of a patient, in the residence of the patient; and 38
(2) Acting under the direction of the medical director of that 39
agency or facility who works in this State. 40
(e) A medication aide - certified at a designated facility under 41
the supervision of an advanced practice registered nurse or 42
registered nurse and in accordance with standard protocols 43
developed by the State Board of Nursing. As used in this paragraph, 44

– 23 –

- *AB346_R1*
“designated facility” has the meaning ascribed to it in 1
NRS 632.0145. 2
(f) Except as otherwise provided in paragraph (g), an advanced 3
emergency medical technician or a paramedic, as authorized by 4
regulation of the State Board of Pharmacy and in accordance with 5
any applicable regulations of: 6
(1) The State Board of Health in a county whose population 7
is less than 100,000; 8
(2) A county board of health in a county whose population is 9
100,000 or more; or 10
(3) A district board of health created pursuant to NRS 11
439.362 or 439.370 in any county. 12
(g) An advanced emergency medical technician or a paramedic 13
who holds an endorsement issued pursuant to NRS 450B.1975, 14
under the direct supervision of a local health officer or a designee of 15
the local health officer pursuant to that section. 16
(h) A respiratory therapist employed in a health care facility. 17
The therapist may possess and administer respiratory products only 18
at the direction of a physician. 19
(i) A dialysis technician, under the direction or supervision of a 20
physician or registered nurse only if the drug or medicine is used for 21
the process of renal dialysis. 22
(j) A medical student or student nurse in the course of his or her 23
studies at an accredited college of medicine or approved school of 24
professional or practical nursing, at the direction of a physician and: 25
(1) In the presence of a physician or a registered nurse; or 26
(2) Under the supervision of a physician or a registered nurse 27
if the student is authorized by the college or school to administer the 28
drug or medicine outside the presence of a physician or nurse. 29
 A medical student or student nurse may administer a dangerous 30
drug in the presence or under the supervision of a registered nurse 31
alone only if the circumstances are such that the registered nurse 32
would be authorized to administer it personally. 33
(k) Any person designated by the head of a correctional 34
institution. 35
(l) An ultimate user or any person designated by the ultimate 36
user pursuant to a written agreement. 37
(m) A holder of a license to engage in radiat ion therapy and 38
radiologic imaging issued pursuant to chapter 653 of NRS, at the 39
direction of a physician and in accordance with any conditions 40
established by regulation of the Board. 41
(n) A chiropractic physician, but only if the drug or medicine is 42
a topical drug used for cooling and stretching external tissue during 43
therapeutic treatments. 44

– 24 –

- *AB346_R1*
(o) A physical therapist, but only if the drug or medicine is a 1
topical drug which is: 2
(1) Used for cooling and stretching external tissue during 3
therapeutic treatments; and 4
(2) Prescribed by a licensed physician for: 5
(I) Iontophoresis; or 6
(II) The transmission of drugs through the skin using 7
ultrasound. 8
(p) In accordance with applicable regulations of the State Board 9
of Health, an employee of a residential facility for groups, as 10
defined in NRS 449.017, pursuant to a written agreement entered 11
into by the ultimate user. 12
(q) A veterinary technician or a veterinary assistant at the 13
direction of his or her supervising veterinarian. 14
(r) In accordance with applicable regulations of the Board, a 15
registered pharmacist who: 16
(1) Is trained in and certified to carry out standards and 17
practices for immunization programs; 18
(2) Is authorized to administer immunizations pursuant to 19
written protocols from a physician; and 20
(3) Administers immunizations in compliance with the 21
“Standards for Immunization Practices” recommended and 22
approved by the Advisory Committee on Immunization Practices of 23
the Centers for Disease Control and Prevention. 24
(s) A registered pharmaci st pursuant to written guidelines and 25
protocols developed pursuant to NRS 639.2629 or a collaborative 26
practice agreement, as defined in NRS 639.0052. 27
(t) A person who is enrolled in a training program to become a 28
physician assistant or anesthesiologist as sistant licensed pursuant to 29
chapter 630 or 633 of NRS, dental hygienist, advanced emergency 30
medical technician, paramedic, respiratory therapist, dialysis 31
technician, physical therapist or veterinary technician or to obtain a 32
license to engage in radiatio n therapy and radiologic imaging 33
pursuant to chapter 653 of NRS if the person possesses and 34
administers the drug or medicine in the same manner and under the 35
same conditions that apply, respectively, to a physician assistant or 36
anesthesiologist assistant licensed pursuant to chapter 630 or 633 of 37
NRS, dental hygienist, advanced emergency medical technician, 38
paramedic, respiratory therapist, dialysis technician, physical 39
therapist, veterinary technician or person licensed to engage in 40
radiation therapy and r adiologic imaging who may possess and 41
administer the drug or medicine, and under the direct supervision of 42
a person licensed or registered to perform the respective medical art 43
or a supervisor of such a person. 44

– 25 –

- *AB346_R1*
(u) A medical assistant, in accordance with applicable 1
regulations of the: 2
(1) Board of Medical Examiners, at the direction of the 3
prescribing physician and under the supervision of a physician or 4
physician assistant. 5
(2) State Board of Osteopathic Medicine, at the direction of 6
the prescribing p hysician and under the supervision of a physician 7
or physician assistant. 8
2. As used in this section, “accredited college of medicine” has 9
the meaning ascribed to it in NRS 453.375. 10
Sec. 37. NRS 454.215 is hereby amended to read as follows: 11
454.215 [A] Except as otherwise provided in sections 5 to 33, 12
inclusive, of this act, a dangerous drug may be dispensed by: 13
1. A registered pharmacist upon the legal prescription from a 14
practitioner or to a pharmacy in a correctional institution upon the 15
written order of the prescribing practitioner in charge; 16
2. A pharmacy in a correctional institution, in case of 17
emergency, upon a written order signed by the chief medical officer; 18
3. A practitioner, or a physician as sistant licensed pursuant to 19
chapter 630 or 633 of NRS if authorized by the Board; 20
4. A registered nurse, when the nurse is engaged in the 21
performance of any public health program approved by the Board; 22
5. A medical intern in the course of his or her internship; 23
6. An advanced practice registered nurse who holds a 24
certificate from the State Board of Pharmacy permitting him or her 25
to dispense dangerous drugs; 26
7. A registered nurse employed at an institution of the 27
Department of Corrections to an offender in that institution; 28
8. A registered pharmacist from an institutional pharmacy 29
pursuant to regulations adopted by the Board; 30
9. A manufacturer or wholesaler dispensing a dialysate drug 31
pursuant to NRS 639.573; or 32
10. A registered nurse to a pat ient at a rural clinic that is 33
designated as such pursuant to NRS 433.233 and that is operated by 34
the Division of Public and Behavioral Health of the Department of 35
Health and Human Services if the nurse is providing mental health 36
services at the rural clinic, 37
 except that no person may dispense a dangerous drug in violation 38
of a regulation adopted by the Board. 39
Sec. 38. NRS 133.065 is hereby amended to read as follows: 40
133.065 1. Except as otherwise provided in subsection 2 or 41
to the extent that it violates public policy, a testator may: 42
[1.] (a) Make a devise conditional upon a devisee’s action or 43
failure to take action or upon the occurrence or nonoccurrence of 44
one or more specified events; and 45

– 26 –

- *AB346_R1*
[2.] (b) Specify the conditions or actions which would 1
disqualify a person from serving or which would constitute cause 2
for removal of a person who is serving in any capacity under the 3
will, including, without limitation, as a personal represent ative, 4
guardian or trustee. 5
2. Any provision in a will executed on or after the effective 6
date of this act that conditions a devise on any person requesting 7
or failing to request a medication designed to end his or her life, 8
revoking such a request or se lf-administering such a medication 9
in accordance with the provisions of sections 5 to 33, inclusive, of 10
this act is unenforceable and void. 11
Sec. 39. NRS 159.054 is hereby amended to read as follows: 12
159.054 1. If the cou rt finds that the proposed protected 13
person is not incapacitated and is not in need of a guardian, the court 14
shall dismiss the petition. 15
2. If the court finds that the proposed protected person is of 16
limited capacity and is in need of a special guardian, the court shall 17
enter an order accordingly and specify the powers and duties of the 18
special guardian. 19
3. If the court finds that appointment of a general guardian is 20
required, the court shall appoint a general guardian of the person, 21
estate, or person and estate of the proposed protected person. 22
4. A proposed protected person shall not be deemed to be in 23
need of a general or special guardian based solely upon a request 24
by the proposed protected person for a medication that is designed 25
to end his or her life or the revocation of such a request if made in 26
accordance with the provisions of sections 5 to 33, inclusive, of 27
this act. 28
Sec. 40. NRS 239.010 is hereby amended to read as follows: 29
239.010 1. Except as otherwise p rovided in this section and 30
NRS 1.4683, 1.4687, 1A.110, 3.2203, 41.0397, 41.071, 49.095, 31
49.293, 62D.420, 62D.440, 62E.516, 62E.620, 62H.025, 62H.030, 32
62H.170, 62H.220, 62H.320, 75A.100, 75A.150, 76.160, 78.152, 33
80.113, 81.850, 82.183, 86.246, 86.54615, 87 .515, 87.5413, 34
87A.200, 87A.580, 87A.640, 88.3355, 88.5927, 88.6067, 88A.345, 35
88A.7345, 89.045, 89.251, 90.730, 91.160, 116.757, 116A.270, 36
116B.880, 118B.026, 119.260, 119.265, 119.267, 119.280, 37
119A.280, 119A.653, 119A.677, 119B.370, 119B.382, 120A.640, 38
120A.690, 125.130, 125B.140, 126.141, 126.161, 126.163, 126.730, 39
127.007, 127.057, 127.130, 127.140, 127.2817, 128.090, 130.312, 40
130.712, 136.050, 159.044, 159A.044, 164.041, 172.075, 172.245, 41
176.01334, 176.01385, 176.015, 176.0625, 176.09129, 176.156, 42
176A.630, 178.39801, 178.4715, 178.5691, 178.5717, 179.495, 43
179A.070, 179A.165, 179D.160, 180.600, 200.3771, 200.3772, 44
200.5095, 200.604, 202.3662, 205.4651, 209.392, 209.3923, 45

– 27 –

- *AB346_R1*
209.3925, 209.419, 209.429, 209.521, 211A.140, 213.010, 213.040, 1
213.095, 213.131, 217.105, 217.110, 217.464, 217.475, 218A.350, 2
218E.625, 218F.150, 218G.130, 218G.240, 218G.350, 218G.615, 3
224.240, 226.462, 226.796, 228.270, 228.450, 228.495, 228.570, 4
231.069, 231.1285, 231.1473, 232.1369, 233.190, 237.300, 5
239.0105, 239.0113, 239.014, 239B.026, 239B.030, 239B.040, 6
239B.050, 239C.140, 239C.210, 239C.230, 239C.250, 239C.270, 7
239C.420, 240.007, 241.020, 241.030, 241.039, 242.105, 244.264, 8
244.335, 247.540, 247.545, 247.550, 247.560, 250.087, 250.130, 9
250.140, 250.145, 250.150, 268.095, 268 .0978, 268.490, 268.910, 10
269.174, 271A.105, 281.195, 281.805, 281A.350, 281A.680, 11
281A.685, 281A.750, 281A.755, 281A.780, 284.4068, 284.4086, 12
286.110, 286.118, 287.0438, 289.025, 289.080, 289.387, 289.830, 13
293.4855, 293.5002, 293.503, 293.504, 293.558, 293.5757, 293.870, 14
293.906, 293.908, 293.909, 293.910, 293B.135, 293D.510, 331.110, 15
332.061, 332.351, 333.333, 333.335, 338.070, 338.1379, 338.1593, 16
338.1725, 338.1727, 348.420, 349.597, 349.775, 353.205, 17
353A.049, 353A.085, 353A.100, 353C.240, 353D.250, 360. 240, 18
360.247, 360.255, 360.755, 361.044, 361.2242, 361.610, 365.138, 19
366.160, 368A.180, 370.257, 370.327, 372A.080, 378.290, 378.300, 20
379.0075, 379.008, 379.1495, 385A.830, 385B.100, 387.626, 21
387.631, 388.1455, 388.259, 388.501, 388.503, 388.513, 388.750, 22
388A.247, 388A.249, 391.033, 391.035, 391.0365, 391.120, 23
391.925, 392.029, 392.147, 392.264, 392.271, 392.315, 392.317, 24
392.325, 392.327, 392.335, 392.850, 393.045, 394.167, 394.16975, 25
394.1698, 394.447, 394.460, 394.465, 396.1415, 396.1425, 396.143, 26
396.159, 396.3295, 396.405, 396.525, 396.535, 396.9685, 27
398A.115, 408.3885, 408.3886, 408.3888, 408.5484, 412.153, 28
414.280, 416.070, 422.2749, 422.305, 422A.342, 422A.350, 29
425.400, 427A.1236, 427A.872, 427A.940, 432.028, 432.205, 30
432B.175, 432B.280, 432B.290, 4 32B.4018, 432B.407, 432B.430, 31
432B.560, 432B.5902, 432C.140, 432C.150, 433.534, 433A.360, 32
439.4941, 439.4988, 439.5282, 439.840, 439.914, 439A.116, 33
439A.124, 439B.420, 439B.754, 439B.760, 439B.845, 440.170, 34
441A.195, 441A.220, 441A.230, 442.330, 442.395, 4 42.735, 35
442.774, 445A.665, 445B.570, 445B.7773, 449.209, 449.245, 36
449.4315, 449A.112, 450.140, 450B.188, 450B.805, 453.164, 37
453.720, 458.055, 458.280, 459.050, 459.3866, 459.555, 459.7056, 38
459.846, 463.120, 463.15993, 463.240, 463.3403, 463.3407, 39
463.790, 467.1005, 480.535, 480.545, 480.935, 480.940, 481.063, 40
481.091, 481.093, 482.170, 482.368, 482.5536, 483.340, 483.363, 41
483.575, 483.659, 483.800, 484A.469, 484B.830, 484B.833, 42
484E.070, 485.316, 501.344, 503.452, 522.040, 534A.031, 561.285, 43
571.160, 584.65 5, 587.877, 598.0964, 598.098, 598A.110, 44
598A.420, 599B.090, 603.070, 603A.210, 604A.303, 604A.710, 45

– 28 –

- *AB346_R1*
604D.500, 604D.600, 612.265, 616B.012, 616B.015, 616B.315, 1
616B.350, 618.341, 618.425, 622.238, 622.310, 623.131, 623A.137, 2
624.110, 624.265, 624.327, 625.425, 625A.185, 628.418, 628B.230, 3
628B.760, 629.043, 629.047, 629.069, 630.133, 630.2671, 4
630.2672, 630.2673, 630.2687, 630.30665, 630.336, 630A.327, 5
630A.555, 631.332, 631.368, 632.121, 632.125, 632.3415, 6
632.3423, 632.405, 633.283, 633.301, 633.427, 633.4715, 633.4716, 7
633.4717, 633.524, 634.055, 634.1303, 634.214, 634A.169, 8
634A.185, 634B.730, 635.111, 635.158, 636.262, 636.342, 637.085, 9
637.145, 637B.192, 637B.288, 638.087, 638.089, 639.183, 10
639.2485, 639.570, 640.075, 640.152, 640A.185, 640A.220, 11
640B.405, 640B.730, 640C.580, 640C.600, 640C.620, 640C.745, 12
640C.760, 640D.135, 640D.190, 640E.225, 640E.340, 641.090, 13
641.221, 641.2215, 641A.191, 641A.217, 641A.262, 641B.170, 14
641B.281, 641B.282, 641C.455, 641C.760, 641D.260, 641D.320, 15
642.524, 643.189, 644A.8 70, 645.180, 645.625, 645A.050, 16
645A.082, 645B.060, 645B.092, 645C.220, 645C.225, 645D.130, 17
645D.135, 645G.510, 645H.320, 645H.330, 647.0945, 647.0947, 18
648.033, 648.197, 649.065, 649.067, 652.126, 652.228, 653.900, 19
654.110, 656.105, 657A.510, 661.115, 665. 130, 665.133, 669.275, 20
669.285, 669A.310, 670B.680, 671.365, 671.415, 673.450, 673.480, 21
675.380, 676A.340, 676A.370, 677.243, 678A.470, 678C.710, 22
678C.800, 679B.122, 679B.124, 679B.152, 679B.159, 679B.190, 23
679B.285, 679B.690, 680A.270, 681A.440, 681B.260, 681B.410, 24
681B.540, 683A.0873, 685A.077, 686A.289, 686B.170, 686C.306, 25
687A.060, 687A.115, 687B.404, 687C.010, 688C.230, 688C.480, 26
688C.490, 689A.696, 692A.117, 692C.190, 692C.3507, 692C.3536, 27
692C.3538, 692C.354, 692C.420, 693A.480, 693A.615, 696B.550, 28
696C.120, 703.196, 704B.325, 706.1725, 706A.230, 710.159, 29
711.600, and section 27 of this act, sections 35, 38 and 41 of 30
chapter 478, Statutes of Nevada 2011 and section 2 of chapter 391, 31
Statutes of Nevada 2013 and unless otherwise declared by law to be 32
confidential, all public books and public records of a governmental 33
entity must be open at all times during office hours to inspection by 34
any person, and may be fully copied or an abstract or memorandum 35
may be prepared from those public books and public recor ds. Any 36
such copies, abstracts or memoranda may be used to supply the 37
general public with copies, abstracts or memoranda of the records or 38
may be used in any other way to the advantage of the governmental 39
entity or of the general public. This section does not supersede or in 40
any manner affect the federal laws governing copyrights or enlarge, 41
diminish or affect in any other manner the rights of a person in any 42
written book or record which is copyrighted pursuant to federal law. 43
2. A governmental entity may not reject a book or record 44
which is copyrighted solely because it is copyrighted. 45

– 29 –

- *AB346_R1*
3. A governmental entity that has legal custody or control of a 1
public book or record shall not deny a request made pursuant to 2
subsection 1 to inspect or copy or receive a copy of a public book or 3
record on the basis that the requested public book or record contains 4
information that is confidential if the governmental entity can 5
redact, delete, conceal or separate, including, without limitation, 6
electronically, the confid ential information from the information 7
included in the public book or record that is not otherwise 8
confidential. 9
4. If requested, a governmental entity shall provide a copy of a 10
public record in an electronic format by means of an electronic 11
medium. Nothing in this subsection requires a governmental entity 12
to provide a copy of a public record in an electronic format or by 13
means of an electronic medium if: 14
(a) The public record: 15
(1) Was not created or prepared in an electronic format; and 16
(2) Is not available in an electronic format; or 17
(b) Providing the public record in an electronic format or by 18
means of an electronic medium would: 19
(1) Give access to proprietary software; or 20
(2) Require the production of information that is confidential 21
and tha t cannot be redacted, deleted, concealed or separated from 22
information that is not otherwise confidential. 23
5. An officer, employee or agent of a governmental entity who 24
has legal custody or control of a public record: 25
(a) Shall not refuse to provide a copy of that public record in the 26
medium that is requested because the officer, employee or agent has 27
already prepared or would prefer to provide the copy in a different 28
medium. 29
(b) Except as otherwise provided in NRS 239.030, shall, upon 30
request, prepare the copy of the public record and shall not require 31
the person who has requested the copy to prepare the copy himself 32
or herself. 33
Sec. 41. NRS 259.010 is hereby amended to read as follows: 34
259.010 1. Every county in this State constitutes a coroner’s 35
district, except a county where a coroner is appointed pursuant to 36
the provisions of NRS 244.163. 37
2. The provisions of this chapter, except NRS 259.025, 38
259.045, 259.047, 259.049, subsections [3] 4 and [4] 5 of NRS 39
259.050, NRS 259.053 and 259.150 to 259.180, inclusive, do not 40
apply to any county where a coroner is appointed pursuant to the 41
provisions of NRS 244.163. 42
Sec. 42. NRS 259.050 is hereby amended to read as follows: 43
259.050 1. When a coroner or the coroner’s deputy is 44
informed that a person has been killed, has committed suicide or has 45

– 30 –

- *AB346_R1*
suddenly died under such circumstances as to afford reasonable 1
ground to suspect that the death has been occasioned by unnatural 2
means, the coroner shall make an appropriate investigation. 3
2. When a coroner or the coroner’s deputy is informed or 4
otherwise discovers that a person has self -administered a 5
medication designed to end his or her life pursuant to sections 5 to 6
33, inclusive, of this act, the coroner: 7
(a) May make an appropriate investigation to the extent 8
necessary to determine that the cause of the terminal condition 9
with which the person was diagnosed; and 10
(b) Must cease investigating the death after determining that 11
the terminal con dition with which the person was diagnosed 12
resulted from a natural cause. 13
3. In all cases where it is apparent or can be reasonably inferred 14
that the death may have been caused by a criminal act, the coroner 15
or the coroner’s deputy shall notify the distr ict attorney of the 16
county where the inquiry is made, and the district attorney shall 17
make an investigation with the assistance of the coroner. If the 18
sheriff is not ex officio the coroner, the coroner shall also notify the 19
sheriff, and the district attorn ey and sheriff shall make 20
the investigation with the assistance of the coroner. 21
[3.] 4. If it is apparent to or can be reasonably inferred by the 22
coroner that a death may have been caused by drug use or 23
poisoning, the coroner shall cause a postmortem ex amination to be 24
performed on the decedent by a forensic pathologist unless the death 25
occurred following a hospitalization stay of 24 hours or more. 26
[4.] 5. A coroner may issue a subpoena for the production of 27
any document, record or material that is dir ectly related or believed 28
to contain evidence related to an investigation by the coroner. 29
[5.] 6. The holding of a coroner’s inquest is within the sound 30
discretion of the district attorney or district judge of the county. An 31
inquest need not be conducted in any case of death manifestly 32
occasioned by natural cause, suicide, accident, motor vehicle crash 33
or when it is publicly known that the death was caused by a person 34
already in custody, but an inquest must be held unless the district 35
attorney or a district judge certifies that no inquest is required. 36
[6.] 7. If an inquest is to be held, the district attorney shall call 37
upon a justice of the peace of the county to preside over it. The 38
justice of the peace shall summon three persons qualified by law to 39
serve as jurors, to appear before the justice of the peace forthwith at 40
the place where the body is or such other place within the county as 41
may be designated by him or her to inquire into the cause of death. 42
[7.] 8. A single inquest may be held w ith respect to more than 43
one death, where all the deaths were occasioned by a common 44
cause. 45

– 31 –

- *AB346_R1*
Sec. 43. NRS 639.238 is hereby amended to read as follows: 1
639.238 1. Prescriptions filled and on file in a pharmacy are 2
not a p ublic record. Except as otherwise provided in NRS 439.597 3
and 639.2357, and section 27 of this act, a pharmacist shall not 4
divulge the contents of any prescription or provide a copy of any 5
prescription, except to: 6
(a) The patient for whom the original prescription was issued; 7
(b) The practitioner who originally issued the prescription; 8
(c) A practitioner who is then treating the patient; 9
(d) A member, inspector or investigator of the Board or an 10
inspector of the Food and Drug Administration or an agent of the 11
Investigation Division of the Department of Public Safety; 12
(e) An agency of state government charged with the 13
responsibility of providing medical care for the patient; 14
(f) An insurance carrier, on receipt of written authorization 15
signed by the pat ient or his or her legal guardian, authorizing the 16
release of such information; 17
(g) Any person authorized by an order of a district court; 18
(h) Any member, inspector or investigator of a professional 19
licensing board which licenses a practitioner who order s 20
prescriptions filled at the pharmacy; 21
(i) Other registered pharmacists for the limited purpose of and to 22
the extent necessary for the exchange of information relating to 23
persons who are suspected of: 24
(1) Misusing prescriptions to obtain excessive amou nts of 25
drugs; or 26
(2) Failing to use a drug in conformity with the directions for 27
its use or taking a drug in combination with other drugs in a manner 28
that could result in injury to that person; 29
(j) A peace officer employed by a local government for the 30
limited purpose of and to the extent necessary: 31
(1) For the investigation of an alleged crime reported by an 32
employee of the pharmacy where the crime was committed; or 33
(2) To carry out a search warrant or subpoena issued 34
pursuant to a court order; or 35
(k) A county coroner, medical examiner or investigator 36
employed by an office of a county coroner for the purpose of: 37
(1) Identifying a deceased person; 38
(2) Determining a cause of death; or 39
(3) Performing other duties authorized by law. 40
2. Any copy of a prescription for a controlled substance or a 41
dangerous drug as defined in chapter 454 of NRS that is issued to a 42
county coroner, medical examiner or investigator employed by an 43
office of a county coroner must be limited to a copy of the 44
prescription filled or on file for: 45

– 32 –

- *AB346_R1*
(a) The person whose name is on the container of the controlled 1
substance or dangerous drug that is found on or near the body of a 2
deceased person; or 3
(b) The deceased person whose cause of death is being 4
determined. 5
3. Except as otherwise provided in NRS 639.2357, any copy of 6
a prescription for a controlled substance or a dangerous drug as 7
defined in chapter 454 of NRS, issued to a person authorized by this 8
section to receive such a copy, must contain all of the information 9
appearing on the original prescription and be clearly marked on its 10
face “Copy, Not Refillable —For Reference Purposes Only.” The 11
copy must bear the name or initials of the registered pharmacist who 12
prepared the copy. 13
4. If a copy of a prescription for any cont rolled substance or a 14
dangerous drug as defined in chapter 454 of NRS is furnished to the 15
customer, the original prescription must be voided and notations 16
made thereon showing the date and the name of the person to whom 17
the copy was furnished. 18
5. As used in this section, “peace officer” does not include: 19
(a) A member of the Police Department of the Nevada System 20
of Higher Education. 21
(b) A school police officer who is appointed or employed 22
pursuant to NRS 391.281. 23
Sec. 44. Chapter 688A of NRS is hereby amended by adding 24
thereto a new section to read as follows: 25
1. An insurer shall not deny a claim under a policy of life 26
insurance or annuity contract, cancel a policy of life insurance or 27
annuity contract or impose an additional charge on a policyholder 28
or beneficiary solely because the insured has, in accordance with 29
the provisions of sections 5 to 33, inclusive, of this act, requested a 30
medication designed to end the life of the insured, revoked such a 31
request or self-administered such a medication. 32
2. Any provision of a policy of life insurance or annuity 33
contract that, in conflict with the provisions of this section, allows 34
the denial of a claim or cancellation of the policy or contract and 35
which is included in a policy or contract that has been or is 36
delivered, issued for delivery or renewed before, on or after the 37
effective date of this act is void and unenforceable. 38
Sec. 45. Chapter 688B of NRS is hereby amended by adding 39
thereto a new section to read as follows: 40
1. An insurer shall not deny a claim under a policy of group 41
life insurance, cancel a policy of group life insurance or impose 42
an additional charge on a policyholder or beneficiary solely 43
because the insured has, in acc ordance with the provisions of 44
sections 5 to 33, inclusive, of this act, requested a medication 45

– 33 –

- *AB346_R1*
designed to end the life of the insured, revoked such a request or 1
self-administered such a medication. 2
2. Any provision of a policy of group life insurance that, in 3
conflict with the provisions of this section, allows the denial of a 4
claim or cancellation of the policy and which is included in a 5
policy that has been or is delivered, issued for delivery or renewed 6
before, on or after the effective date of this act is void and 7
unenforceable. 8
Sec. 46. NRS 688B.040 is hereby amended to read as follows: 9
688B.040 No policy of group life insurance shall be delivered 10
in this State unless it contains in substance the provisions set forth in 11
NRS 688B.040 to 688B.150, inclusive, and section 45 of this act or 12
provisions which in the opinion of the Commissioner are more 13
favorable to the persons insured, or at least as favorable to the 14
persons insured and more favorable to the policyholder; except: 15
1. NRS 688B.100 to 688B.140, inclusive, do not apply to 16
policies issued to a creditor to insure debtors of such creditor; 17
2. The standard provisions required for individual life 18
insurance policies do not apply to group life insurance policies; and 19
3. If the group life insurance policy is on a plan of insurance 20
other than the term plan, it shall contain a nonforfeiture provision or 21
provisions which in the opinion of the Commissioner is or are 22
equitable to the insured persons and to the policyh older; but nothing 23
in this subsection shall be construed to require that group life 24
insurance policies contain the same nonforfeiture provisions as are 25
required for individual life insurance policies. 26
Sec. 47. Not later tha n 45 days after the effective date of this 27
act, the Division of Public and Behavioral Health of the Department 28
of Health and Human Services shall prescribe and make available 29
on an Internet website maintained by the Division the forms for 30
making the reports required by section 27 of this act. 31
Sec. 48. This act becomes effective upon passage and 32
approval. 33

H